HRT Financial LP lifted its holdings in Phibro Animal Health Co. (NASDAQ:PAHC – Get Rating) by 78.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 47,570 shares of the company’s stock after buying an additional 20,937 shares during the quarter. HRT Financial LP owned approximately 0.12% of Phibro Animal Health worth $637,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. BlackRock Inc. boosted its stake in shares of Phibro Animal Health by 5.7% during the first quarter. BlackRock Inc. now owns 3,789,646 shares of the company’s stock valued at $75,604,000 after purchasing an additional 203,652 shares during the period. Vanguard Group Inc. boosted its position in Phibro Animal Health by 1.7% in the 3rd quarter. Vanguard Group Inc. now owns 2,311,899 shares of the company’s stock valued at $30,725,000 after buying an additional 38,193 shares during the period. Pzena Investment Management LLC increased its position in shares of Phibro Animal Health by 2.5% during the fourth quarter. Pzena Investment Management LLC now owns 1,969,236 shares of the company’s stock worth $26,407,000 after acquiring an additional 47,513 shares during the period. State Street Corp raised its stake in shares of Phibro Animal Health by 2.7% during the third quarter. State Street Corp now owns 886,231 shares of the company’s stock valued at $11,778,000 after acquiring an additional 23,483 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in Phibro Animal Health by 1.5% in the first quarter. Goldman Sachs Group Inc. now owns 685,470 shares of the company’s stock worth $13,675,000 after purchasing an additional 10,065 shares in the last quarter. 49.21% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on PAHC shares. Morgan Stanley decreased their target price on Phibro Animal Health from $20.00 to $19.00 and set an “equal weight” rating for the company in a research report on Thursday, February 9th. StockNews.com raised shares of Phibro Animal Health from a “hold” rating to a “buy” rating in a research note on Friday. One research analyst has rated the stock with a sell rating, one has given a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $18.00.
Phibro Animal Health Stock Up 6.4 %
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 28th. Investors of record on Wednesday, June 7th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 3.49%. The ex-dividend date of this dividend is Tuesday, June 6th. Phibro Animal Health’s payout ratio is currently 67.61%.
About Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines.
Featured Stories
- Get a free copy of the StockNews.com research report on Phibro Animal Health (PAHC)
- Trading Channel Breakout in Lululemon Brought by Earnings
- What Should Investors Make of These 3 Dividend Cuts?
- Constellation Brands Taps into Growth: Analysts Bullish on Stock
- CrowdStrike: Another Tech Stock to Buy on the Dip
- Salesforce: Time to Snap it Up as the Market Buys the Dip?
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.
